Overview
Specialty products maker's Q4 sales missed analyst expectations
Company achieved $222 mln debt reduction in fiscal 2025
Record production year in Specialty Products & Solutions segment
Outlook
Calumet plans to complete MaxSAF 150 expansion in Q2 2026
Company expects continued growth driven by structural cost reductions
Result Drivers
COST REDUCTIONS - Calumet achieved $100 mln in cost reductions, aiding in $222 mln debt reduction and nearly 30% EBITDA growth
SPECIALTY PRODUCTS GROWTH - Record production and strong margins in Specialty Products & Solutions segment boosted results
RENEWABLES CHALLENGES - Montana Renewables faced low industry diesel margins but benefited from cost reductions
Company press release: ID:nPn7sSVLMa
Key Details
Metric | Beat/Miss | Actual | Consensus Estimate |
Q4 Sales | Miss | $1.04 bln | $1.06 bln (6 Analysts) |
Q4 EPS | -$0.43 | ||
Q4 Net Income | -$37.30 mln | ||
Q4 Adjusted EBITDA | $48.40 mln |
Analyst Coverage
The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 3 "strong buy" or "buy", 3 "hold" and no "sell" or "strong sell"
The average consensus recommendation for the oil & gas refining and marketing peer group is "buy"
Wall Street's median 12-month price target for Calumet Inc is $26.00, about 14% below its February 26 closing price of $30.22
For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.
(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)